Oral Protein Supplementation Following Non-bariatric Surgery
A Randomized Trial of Oral Protein Supplementation Following Non-bariatric Abdominal Surgery
1 other identifier
interventional
62
0 countries
N/A
Brief Summary
Investigators performed a randomized controlled trial of 62 patients undergoing elective abdominal operations. The treatment group was provided a liquid protein supplement and instructed to take a dose three times daily for the first 20 postoperative days. Investigators followed patients for six months and compared wound healing and changes in weight and laboratory values.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2011
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2012
CompletedFirst Submitted
Initial submission to the registry
December 1, 2015
CompletedFirst Posted
Study publicly available on registry
December 4, 2015
CompletedDecember 4, 2015
December 1, 2015
10 months
December 1, 2015
December 2, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Change in weight
Mean preoperative weight compared to mean postoperative weight at each follow-up appointment. Weight recorded in pounds, subsequent measurements at each postoperative point were normalized to the preoperative weight and reported as a relative percentage of the preoperative weight.
Preoperative, and then postoperative at 1-2 weeks, 3 weeks, 1 month, 2 months, 3 months, 6 months
Secondary Outcomes (5)
Wound healing
Preoperative, and then postoperative at 1-2 weeks, 3 weeks, 1 month, 2 months, 3 months, 6 months
Change in white blood cell count (1x10 3/ uL)
Preoperative, and then postoperative at 1-2 weeks, 3 weeks, 1 month, 2 months, 3 months, 6 months
Change in total protein (g/ dL)
Preoperative, and then postoperative at 1-2 weeks, 3 weeks, 1 month, 2 months, 3 months, 6 months
Change in albumin (g/ dL)
Preoperative, and then postoperative at 1-2 weeks, 3 weeks, 1 month, 2 months, 3 months, 6 months
Change in prealbumin (mg/ dL)
Preoperative, and then postoperative at 1-2 weeks, 3 weeks, 1 month, 2 months, 3 months, 6 months
Study Arms (2)
Control
PLACEBO COMPARATORThe patients in the control group did not receive any supplementation, and were directed to follow the dietary guidelines of their surgeon.
Treatment
EXPERIMENTALPatients were instructed to consume one ounce (containing 16 grams of protein) of the supplement three times daily. No other modifications were made to the patient's diet. Patients were provided with a total of 60 doses, which would last 20 days if they consumed each dose as instructed.
Interventions
Prostat AWC- patients received protein supplementation after surgery
Placebo- Patients did not take any protein supplementation after surgery
Eligibility Criteria
You may qualify if:
- patients scheduled to undergo abdominal surgery \[cholecystectomy, ventral hernia repair, colectomy, non-bariatric gastric surgery, appendectomy, small bowel resection, lysis of adhesions, liver resection, splenectomy, proctectomy, stoma construction, pancreatic surgery, duodenal surgery, adrenal surgery, renal surgery, or cystectomy\]
You may not qualify if:
- Age less than 18 years
- Pregnant
- Abdominal surgery within the past 6 months
- Inability to attend follow-up appointments for at least 6 months
- Liver failure (Child-Pugh Class B or C) or kidney failure (glomerular filtration rate (GFR) less than 30).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Eisenhower Army Medical Centerlead
- Medical Nutrition USA, Inc.collaborator
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Christina Riojas, General Surgeon
Study Record Dates
First Submitted
December 1, 2015
First Posted
December 4, 2015
Study Start
August 1, 2011
Primary Completion
June 1, 2012
Study Completion
June 1, 2012
Last Updated
December 4, 2015
Record last verified: 2015-12